Linklaters, Kirkland Rep On Takeda $414M Surgical Patch Divestment

Law360 (September 16, 2020, 3:11 PM EDT) -- Takeda said Wednesday it is selling off a surgical patch business for €350 million (about $414 million) to Corza Health in a deal guided by Linklaters LLP and Kirkland & Ellis LLP that furthers the Japanese pharmaceutical giant's goal of selling assets and simplifying operations.

Linkaters-guided Takeda Pharmaceutical Co. Ltd.'s sale of its TachoSil surgical sealant patch to Kirkland-represented Corza Health Inc. comes after previous plans to sell the product to Johnson & Johnson were scrapped in April after U.S. and European regulators raised antitrust concerns.

The deal is but one of a number of divestments recently taken by Takeda as part of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!